Announcements Trials

Browse Landscape

Phase

Phase 3 3 Phase 2 2 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Ovarian Neoplasms 1

Interventions

Saline Solution 6 Fentanyl 6 Sodium Chloride 5 Letrozole 5 Dexamethasone 5 Pregabalin 4 Ketamine 4 Goserelin 4 Gemcitabine 4 Bevacizumab 4 Tranexamic Acid 3 Photochemotherapy 3 Pemetrexed 3 Paclitaxel 3 Metformin 3 Leuprolide 3 Docetaxel 3 Cyclophosphamide 3 Carboplatin 3 Capecitabine 3 Acetaminophen 3 ulipristal acetate 2 sodium glycididazole 2 nilotinib 2 liposomal doxorubicin 2 human papillomavirus vaccine, L1 type 16, 18 2 flurbiprofen axetil 2 fludarabine 2 fluciclovine F-18 2 epoetin beta 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Trabectedin × Clear all

NCT03164980 2025-03-20

COMPASS

North Eastern German Society of Gynaecological Oncology

Phase 4 Terminated

89 enrolled 20 charts

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡